20-hydroxy-5,8,11,14-eicosatetraenoic acid and Injury, Myocardial Reperfusion

20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Injury, Myocardial Reperfusion in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (75.00)	29.6817
2010's	2 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Han, Y; Li, X; Sun, C; Tan, J; Tang, H; Zeng, Q; Zhao, H	1
Ji, H; Lu, G; Ren, Y; Song, Y; Wei, Y; Xu, M; Xu, Y	1
Ao, Y; Cheng, H; Li, Y; Lv, X; Peng, R; Wan, J; Yang, J	1
Campbell, WB; Endsley, MP; Falck, JR; Gross, ER; Gross, GJ; Isbell, MA; Moore, JM; Nithipatikom, K	1
Falck, JR; Gross, ER; Gross, GJ; Isbell, M; Moore, J; Nithipatikom, K	1
Doggrell, SA	1
Campbell, WB; Endsley, MP; Falck, JR; Gross, GJ; Isbell, MA; Moore, JM; Nithipatikom, K	1
Falck, JR; Gross, GJ; Isbell, MA; Moore, JM; Nithipatikom, K	1

Reviews

1 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Injury, Myocardial Reperfusion

Article	Year
Taking the 20-HETE out of the cardiovascular system: the potential of 20-HETE synthesis inhibitors. Current opinion in investigational drugs (London, England : 2000), 2005, Volume: 6, Issue:9 Topics: Amidines; Angiogenesis Inhibitors; Animals; Cerebrovascular Circulation; Enzyme Inhibitors; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Myocardial Reperfusion Injury; Oligonucleotides, Antisense	2005

Article

Year

Taking the 20-HETE out of the cardiovascular system: the potential of 20-HETE synthesis inhibitors.

Current opinion in investigational drugs (London, England : 2000), 2005, Volume: 6, Issue:9

Topics: Amidines; Angiogenesis Inhibitors; Animals; Cerebrovascular Circulation; Enzyme Inhibitors; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Myocardial Reperfusion Injury; Oligonucleotides, Antisense

2005

Other Studies

7 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Injury, Myocardial Reperfusion

Article	Year
20-Hydroxyeicosatetraenoic acid mediates isolated heart ischemia/reperfusion injury by increasing NADPH oxidase-derived reactive oxygen species production. Circulation journal : official journal of the Japanese Circulation Society, 2013, Volume: 77, Issue:7 Topics: Acetophenones; Animals; Apoptosis; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Hydroxyeicosatetraenoic Acids; Male; Membrane Glycoproteins; Myocardial Reperfusion Injury; Myocardium; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species	2013
The cardioprotection of dihydrotanshinone I against myocardial ischemia-reperfusion injury via inhibition of arachidonic acid ω-hydroxylase. Canadian journal of physiology and pharmacology, 2016, Volume: 94, Issue:12 Topics: Abietanes; Animals; Cardiotonic Agents; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Male; Myocardial Reperfusion Injury; Random Allocation; Rats; Rats, Sprague-Dawley; Salvia miltiorrhiza	2016
Cytochrome P450 omega-hydroxylase inhibition reduces cardiomyocyte apoptosis via activation of ERK1/2 signaling in rat myocardial ischemia-reperfusion. European journal of pharmacology, 2008, Oct-31, Volume: 596, Issue:1-3 Topics: Amides; Amidines; Animals; Apoptosis; Caspase 3; Cytochrome P-450 CYP4A; Enzyme Activation; Fatty Acids, Unsaturated; Hydroxyeicosatetraenoic Acids; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Reperfusion Injury; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Signal Transduction; Sulfones	2008
Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway. Circulation research, 2004, Oct-15, Volume: 95, Issue:8 Topics: 8,11,14-Eicosatrienoic Acid; Amides; Animals; Arachidonic Acids; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dogs; Fatty Acids, Unsaturated; Female; Hydroxyeicosatetraenoic Acids; Isoenzymes; Male; Miconazole; Microsomes; Mixed Function Oxygenases; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Sulfones	2004
Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited. Cardiovascular research, 2005, Oct-01, Volume: 68, Issue:1 Topics: 8,11,14-Eicosatrienoic Acid; Adenosine Triphosphate; Animals; Arachidonic Acid; Cytochrome P-450 Enzyme System; Humans; Hydroxyeicosatetraenoic Acids; Myocardial Reperfusion Injury; Myocardium; Potassium Channels; Prostaglandins; Signal Transduction	2005
Effects of selective inhibition of cytochrome P-450 omega-hydroxylases and ischemic preconditioning in myocardial protection. American journal of physiology. Heart and circulatory physiology, 2006, Volume: 290, Issue:2 Topics: Amides; Animals; Arachidonic Acid; Cardiotonic Agents; Coronary Circulation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dogs; Female; Hemodynamics; Hydroxyeicosatetraenoic Acids; Ischemic Preconditioning, Myocardial; Male; Mixed Function Oxygenases; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Sulfones	2006
Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury. American journal of physiology. Heart and circulatory physiology, 2006, Volume: 291, Issue:2 Topics: 8,11,14-Eicosatrienoic Acid; Amides; Animals; Arachidonic Acid; Cardiotonic Agents; Coronary Circulation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dogs; Enzyme Inhibitors; Hemodynamics; Hydroxyeicosatetraenoic Acids; Mixed Function Oxygenases; Myocardial Ischemia; Myocardial Reperfusion Injury; Spectrometry, Mass, Electrospray Ionization; Sulfones	2006